article · Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology/Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology
Schistosomiasis is a fatal parasitic disease caused by trematode worms of the genus Schistosoma. Bee venom (BV) was used as a potential drug for many diseases due to its pharmacologically active molecules. The major biopeptides of Apis mellifera V are melittin (MEL) and phospholipase A2 (PLA2) which have a wide range of biological activities. The present in vitro study aimed to elucidate the anti-inflammatory effects of MEL and PLA2 on murine splenocytes activated with Schistosoma mansoni egg and worm antigens (SEA and SWA). Splenocytes were collected from the spleen of Balb/c mice, and then cultured in the presence of MEL or PLA2. Proliferation was estimated by MTT assay. Levels of tumor necrosis factor-α (TNF-α), Interleukin-10 (IL-10) and nuclear factor-κB (NF‐κB) were estimated by enzyme-linked immunosorbent assay (ELISA). MEL and PLA2 induced proliferation of murine primary splenocytes in a concentration and time-dependent pattern, where the proliferation of 24 h incubated splenocytes was significantly (p < 0.05) increased at 0.5 μg/ml and 0.05 μg/ml concentrations of MEL and PLA2, respectively compared to non-stimulated cells. The results indicated that MEL and PLA2 modulate an inflammatory reaction by decreasing the levels of both TNF-α and NF‐κB and significantly elevating IL-10 levels. These results may suggest their potent anti-inflammatory effects that can be applied in the treatment of many inflammatory diseases including S. mansoni infection. Further, in vivo studies are required to confirm these results.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/eajbsc.2024.371726
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.